Peer Review History
| Original SubmissionJanuary 17, 2024 |
|---|
|
Dear Dr. yao, Thank you very much for submitting your manuscript "Two types of toxin-antitoxin systems coordinately stabilize the integrative and conjugative element conferring multiple drug resistance" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations. Specifically, your manuscript was evaluated by three experts in the field. All three reviewers find your work to be interesting, well-presented, of high quality and rigor with broad implications for antibiotic resistance and bacterial evolution. The reviewers have mainly minor comments for you to address, with the exception of Reviewer #2, who provides comments and suggestions for additional experiments to solidify your claims regarding AbiEi and SezA-binding and ICE stability. I would ask that you, in some way, address and respond to the comments and suggestions from Reviewer #2 in a revised manuscript through incorporating additional data or discussing the issues raised in by the Reviewer in the text. Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Anders P Hakansson, Ph.D. Academic Editor PLOS Pathogens Michael Wessels Section Editor PLOS Pathogens Michael Malim Editor-in-Chief PLOS Pathogens *********************** Your manuscript has been evaluated by three experts in the field. All three reviewers find your work to be interesting, well-presented, of high quality and rigor with broad implications for antibiotic resistance and bacterial evolution. The reviewers have mainly minor comments for you to address, with the exception of Reviewer #2, who provides comments and suggestions for additional experiments to solidify your claims regarding AbiEi and SezA-binding and ICE stability. I would ask that you, in some way, address and respond to the comments and suggestions from Reviewer #2 in a revised manuscript through incorporating additional data or discussing the issues raised in by the Reviewer in the text. Reviewer Comments (if any, and for reference): Reviewer's Responses to Questions Part I - Summary Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship. Reviewer #1: The manuscript is well presented in general. The amount of work is overwhelming, and very interesting results are convincing and well discussed. I have only a few comments that I would like the authors to consider. Reviewer #2: This manuscript investigates how two antitoxins, SezA and AbiEi, promote the stability of an integrative and conjugative element (ICE) in the genome of Streptococcus suis. The antitoxins, rather than the toxins, were found to be important for maintaining the genetic stability of the ICE. AbiEi was found to interact with the oriT, and SezA was found to bind in the attL site. This interaction likely impedes the excision and subsequent loss of the ICE, highlighting a novel mechanism of ICE stabilization mediated by antitoxins. The results are exciting. However, there are a few issues that lessen the impact of the work. Reviewer #3: Upon reviewing the manuscript focused on the study of toxin-antitoxin (TA) systems, particularly SezAT and AbiE, within Streptococcus suis, I can evaluate the depth of the research and its contributions to our understanding of bacterial resistance mechanisms. The detailed examination of the cross-regulation between two distinct TA pairs and their influence on the stability of integrative and conjugative elements (ICEs) is noteworthy. This aspect of the study not only highlights a novel and critical mechanism but also sheds light on the broader implications for antibiotic resistance and bacterial evolution. The authors have provided robust evidence to support their findings, demonstrating a high level of scientific rigor and innovation. Their work addresses a gap in the current literature, offering new insights that could pave the way for developing more effective strategies against antibiotic-resistant bacteria. Given the manuscript's clear relevance to the ongoing challenges in microbiology and public health, its potential to inform future research, and its contribution to the scientific community's understanding of complex bacterial systems, I recommend its publication in PLOS pathogens. The study is well-presented, methodologically sound, and represents an advancement in the field of microbial genetics and antibiotic resistance. In conclusion, this manuscript is not only timely but also of importance to researchers, and clinicians involved in combating antibiotic resistance. Its publication would enrich the academic discourse and inspire further research in this study area. ********** Part II – Major Issues: Key Experiments Required for Acceptance Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions. Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject". Reviewer #1: None Reviewer #2: The authors propose an intriguing interaction between AbiEi-oriT and SezA-AttL contributing to the stabilization of ICE elements. However, the evidence presented does not fully substantiate this hypothesis. To bolster their claims, the authors should consider generating deletion mutants for the DNA-binding domains of AbiEi and SezA. This would provide crucial insights into the role of antitoxin DNA-binding in ICE stability. Furthermore, a double deletion mutant involving oriT and attL, in the genetic background of ∆SezA-AbiEi mutants, would be invaluable in supporting the hypothesis if the ICE stability could be restored. What is the extrachromosomal copy number of the attL deletion mutant? Reviewer #3: (No Response) ********** Part III – Minor Issues: Editorial and Data Presentation Modifications Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. Reviewer #1: GENERAL: 1. I would recommend being more specific in the title: type of TA, bacterial species, and type of ICE. As it is now, it has little information. 2. Although in general the English is correct, it needs editing throughout. SPECIFIC: 3. Lines 140 and around it: a recent review on the hypothesis and roles of type II TAs, with a focus focusing on PezAT should be be cited (https://doi.org/10.1093/femsre/fuad052). 4. Line 172: “Numerous studies…” but they cite just two papers. Correct this or cite at least 3-5 more papers. 5. Line 251 and following: In many cases, the antitoxin binds poorly to its DNA target, needing the toxin as a co-repressor, which does not seem to be the case here. It would be interesting if the authors discuss this. 6. Discussion: lines 440-450: Cite the work on ICESag-rpsl, which encodes a functional relaxase involved in the mobilization of the element and also in plasmid mobilization (https://doi.org/10.1098/rsob.160084) Reviewer #2: In Figures 3H and 3I, the omission of protein concentrations leaves a gap in understanding the experimental setup, especially in estimating the dissociation constant. The inclusion of these details would significantly enhance the interpretability of the results. The Kd values mentioned on lines 288 and 315 warrant a second look, as transcription factors are known to bind DNA with nanomolar affinity. This discrepancy suggests a possible miscalculation or misinterpretation that should be addressed to ensure the accuracy of the findings. Line 82, please provide the full name of SXT. All of the figures' resolutions are too low. Reviewer #3: (No Response) ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Manuel Espinosa Reviewer #2: No Reviewer #3: No Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols References: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. |
| Revision 1 |
|
Dear Dr. yao, We are pleased to inform you that your manuscript 'Type Ⅱ and Ⅳ toxin-antitoxin systems coordinately stabilize the integrative and conjugative element of the ICESa2603 family conferring multiple drug resistance in Streptococcus suis' has been provisionally accepted for publication in PLOS Pathogens. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Anders P Hakansson, Ph.D. Academic Editor PLOS Pathogens Michael Wessels Section Editor PLOS Pathogens Michael Malim Editor-in-Chief PLOS Pathogens *********************************************************** Reviewer Comments (if any, and for reference): |
| Formally Accepted |
|
Dear Dr. Yao, We are delighted to inform you that your manuscript, "Type Ⅱ and Ⅳ toxin-antitoxin systems coordinately stabilize the integrative and conjugative element of the ICESa2603 family conferring multiple drug resistance in Streptococcus suis," has been formally accepted for publication in PLOS Pathogens. We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Michael Malim Editor-in-Chief PLOS Pathogens |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .